Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.83

-0.55

-0.28

0

Details

Expected EPS

-0.668

Actual EPS

-0.7

Surprise EPS

-0.03

Surprise Percent

+4.79%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.7 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.